Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction

Neuron

Volumn 71, Issue 3, 2011, Pages 498-511

  Bruchas, Michael R ^a,d   Schindler, Abigail G ^a   Shankar, Haripriya ^a   Messinger, Daniel I ^a   Miyatake, Mayumi ^a   Land, Benjamin B ^a,b   Lemos, Julia C ^a,b   Hagan, Catherine E ^b   Neumaier, John F ^a,b   Quintana, Albert ^c   Palmiter, Richard D ^c   Chavkin, Charles ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; COCAINE; KAPPA OPIATE RECEPTOR AGONIST; MITOGEN ACTIVATED PROTEIN KINASE 14; PAROXETINE; TAMOXIFEN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CELL MEMBRANE; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG INHIBITION; DRUG SEEKING BEHAVIOR; ENZYME ACTIVATION; GENE DELETION; MALE; MOUSE; NEUROTRANSMITTER UPTAKE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONINERGIC NERVE CELL; STRESS;

ANIMALS; AVOIDANCE LEARNING; CHOICE BEHAVIOR; COCAINE-RELATED DISORDERS; CONDITIONING (PSYCHOLOGY); DEPRESSION; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 14; NEURONS; RAPHE NUCLEI; RECEPTORS, OPIOID; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 79961197759     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2011.06.011     Document Type: Article

References (79)

1. Ahmed B.Y., Chakravarthy S., Eggers R., Hermens W.T.J.M.C., Zhang J.Y., Niclou S.P., Levelt C., Sablitzky F., Anderson P.N., Lieberman A.R., Verhaagen J. Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors. BMC Neurosci. 2004, 5:4.
2. Ansorge M.S., Zhou M., Lira A., Hen R., Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306:879-881.
3. Avgustinovich D.F., Kovalenko I.L. Formation of behavioral pathology in female C57BL/6J mice exposed to prolonged negative psychoemotional conditions. Neurosci. Behav. Physiol. 2005, 35:959-967.
4. Bal N., Figueras G., Vilaró M.T., Suñol C., Artigas F. Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain. Eur. J. Neurosci. 1997, 9:1728-1738.
5. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:525-557.
6. Bari A., Theobald D.E., Caprioli D., Mar A.C., Aidoo-Micah A., Dalley J.W., Robbins T.W. Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology 2010, 35:1290-1301.
7. Beidel D.C., Rao P.A., Scharfstein L., Wong N., Alfano C.A. Social skills and social phobia: an investigation of DSM-IV subtypes. Behav. Res. Ther. 2010, 48:992-1001.
8. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner C.H., Heils A., Mossner R., Westphal H., Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (" Ecstasy" ) in serotonin transporter-deficient mice. Mol. Pharmacol. 1998, 53:649-655.
9. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
10. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010, 68:815-834.
11. Bruchas M.R., Macey T.A., Lowe J., Chavkin C. Kappa opioid receptor activation of p38 MAPK is GRK3 and arrestin dependent in neurons and astrocytes. J. Biol. Chem. 2006, 281:18081-18089.
12. Bruchas M.R., Land B.B., Aita M., Xu M., Barot S.K., Li S., Chavkin C. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J. Neurosci. 2007, 27:11614-11623.
13. Bruchas M.R., Land B.B., Chavkin C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 2010, 1314:44-55.
14. Burnette W.B., Bailey M.D., Kukoyi S., Blakely R.D., Trowbridge C.G., Justice J.B. Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. Anal. Chem. 1996, 68:2932-2938.
15. Cao J.L., Covington H.E., Friedman A.K., Wilkinson M.B., Walsh J.J., Cooper D.C., Nestler E.J., Han M.H. Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action. J. Neurosci. 2010, 30:16453-16458.
16. Carlezon W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., Nestler E.J. Regulation of cocaine reward by CREB. Science 1998, 282:2272-2275.
17. Coulthard L.R., White D.E., Jones D.L., McDermott M.F., Burchill S.A. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol. Med. 2009, 15:369-379.
18. Daws L.C. Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol. Ther. 2009, 121:89-99.
19. Earles C., Schenk J.O. Rotating disk electrode voltammetric measurements of dopamine transporter activity: an analytical evaluation. Anal. Biochem. 1998, 264:191-198.
20. Eriksson T.M., Delagrange P., Spedding M., Popoli M., Mathé A.A., Ogren S.O., Svenningsson P. Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Mol. Psychiatry 2011, in press. Published online January 18, 2011. 10.1038/mp.2010.131.
21. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4:1002-1012.
22. Gingrich J.A., Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 2001, 155:413-421.
23. Gong K., Li Z., Xu M., Du J., Lv Z., Zhang Y. A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors. J. Biol. Chem. 2008, 283:29028-29036.
24. Haenisch B., Bönisch H. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol. Ther. 2011, 129:352-368.
25. Hagan C.E., Neumaier J.F., Schenk J.O. Rotating disk electrode voltammetric measurements of serotonin transporter kinetics in synaptosomes. J. Neurosci. Methods 2010, 193:29-38.
26. Haubensak W., Kunwar P.S., Cai H., Ciocchi S., Wall N.R., Ponnusamy R., Biag J., Dong H.W., Deisseroth K., Callaway E.M., et al. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 2010, 468:270-276.
27. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci. Biobehav. Rev. 2006, 30:203-214.
28. Hirrlinger P.G., Scheller A., Braun C., Hirrlinger J., Kirchhoff F. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2. Glia 2006, 54:11-20.
29. Hirst W.D., Price G.W., Rattray M., Wilkin G.P. Serotonin transporters in adult rat brain astrocytes revealed by [3H]5-HT uptake into glial plasmalemmal vesicles. Neurochem. Int. 1998, 33:11-22.
30. Holmes A. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci. Biobehav. Rev. 2008, 32:1293-1314.
31. Kirby L.G., Freeman-Daniels E., Lemos J.C., Nunan J.D., Lamy C., Akanwa A., Beck S.G. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J. Neurosci. 2008, 28:12927-12937.
32. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
33. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
34. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
35. Land B.B., Bruchas M.R., Lemos J., Melief E., Xu M., Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin-kappa opioid system. J. Neurosci. 2008, 28:407-414.
36. Land B.B., Bruchas M.R., Schattauer S., Giardino W.J., Aita M., Messinger D., Hnasko T.S., Palmiter R.D., Chavkin C. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc. Natl. Acad. Sci. USA 2009, 106:19168-19173.
37. Lee S.H., Park J., Che Y., Han P.L., Lee J.K. Constitutive activity and differential localization of p38alpha and p38beta MAPKs in adult mouse brain. J. Neurosci. Res. 2000, 60:623-631.
38. Lemos J.C., Zhang G., Walsh T., Kirby L.G., Akanwa A., Brooks-Kayal A., Beck S.G. Stress-hyperresponsive WKY rats demonstrate depressed dorsal raphe neuronal excitability and dysregulated CRF-mediated responses. Neuropsychopharmacology 2011, 36:721-734.
39. Liu C., Maejima T., Wyler S.C., Casadesus G., Herlitze S., Deneris E.S. Pet-1 is required across different stages of life to regulate serotonergic function. Nat. Neurosci. 2010, 13:1190-1198.
40. Lowry C.A., Hale M.W., Evans A.K., Heerkens J., Staub D.R., Gasser P.J., Shekhar A. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann. N Y Acad. Sci. 2008, 1148:86-94.
41. MacGillivray L., Lagrou L.M., Reynolds K.B., Rosebush P.I., Mazurek M.F. Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificity. Neuroscience 2010, 171:407-420.
42. McElvain J.S., Schenk J.O. Studies of the mechanism of inhibition of the dopamine uptake carrier by cocaine in vitro using rotating disk electrode voltammetry. Ann. N Y Acad. Sci. 1992, 654:480-482.
43. McLaughlin J.P., Marton-Popovici M., Chavkin C. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J. Neurosci. 2003, 23:5674-5683.
44. Miczek K.A., Yap J.J., Covington H.E. Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol. Ther. 2008, 120:102-128.
45. Murphy D.L., Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 2008, 9:85-96.
46. Nakamura K., Hasegawa H. Developmental role of tryptophan hydroxylase in the nervous system. Mol. Neurobiol. 2007, 35:45-54.
47. Narboux-Nême N., Pavone L.M., Avallone L., Zhuang X., Gaspar P. Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs). Neuropharmacology 2008, 55:994-1005.
48. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169.
49. Nishida K., Yamaguchi O., Hirotani S., Hikoso S., Higuchi Y., Watanabe T., Takeda T., Osuka S., Morita T., Kondoh G., et al. p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol. Cell. Biol. 2004, 24:10611-10620.
50. Pamplona F.A., Henes K., Micale V., Mauch C.P., Takahashi R.N., Wotjak C.T. Prolonged fear incubation leads to generalized avoidance behavior in mice. J. Psychiatr. Res. 2011, 45:354-360.
51. Paul E.D., Hale M.W., Lukkes J.L., Valentine M.J., Sarchet D.M., Lowry C.A. Repeated social defeat increases reactive emotional coping behavior and alters functional responses in serotonergic neurons in the rat dorsal raphe nucleus. Physiol. Behav. 2011, 104:272-282.
52. Pickel V.M., Chan J. Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens. J. Neurosci. 1999, 19:7356-7366.
53. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
54. Ramamoorthy S., Samuvel D.J., Buck E.R., Rudnick G., Jayanthi L.D. Phosphorylation of threonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP. J. Biol. Chem. 2007, 282:11639-11647.
55. Raman M., Chen W., Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 2007, 26:3100-3112.
56. Ravna A.W., Sylte I., Dahl S.G. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters. J. Pharmacol. Exp. Ther. 2003, 307:34-41.
57. Richardson-Jones J.W., Craige C.P., Guiard B.P., Stephen A., Metzger K.L., Kung H.F., Gardier A.M., Dranovsky A., David D.J., Beck S.G., et al. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 2010, 65:40-52.
58. Roche M., Commons K.G., Peoples A., Valentino R.J. Circuitry underlying regulation of the serotonergic system by swim stress. J. Neurosci. 2003, 23:970-977.
59. Sajikumar S., Korte M. Metaplasticity governs compartmentalization of synaptic tagging and capture through brain-derived neurotrophic factor (BDNF) and protein kinase Mzeta (PKMzeta). Proc. Natl. Acad. Sci. USA 2011, 108:2551-2556.
60. Samuvel D.J., Jayanthi L.D., Bhat N.R., Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J. Neurosci. 2005, 25:29-41.
61. Scott M.M., Krueger K.C., Deneris E.S. A differentially autoregulated Pet-1 enhancer region is a critical target of the transcriptional cascade that governs serotonin neuron development. J. Neurosci. 2005, 25:2628-2636.
62. Shaham Y., Hope B.T. The role of neuroadaptations in relapse to drug seeking. Nat. Neurosci. 2005, 8:1437-1439.
63. Shippenberg T.S., Herz A. Differential effects of mu and kappa opioid systems on motivational processes. NIDA Res. Monographs 1986, 75:563-566.
64. Siegfried K. Cognitive symptoms in late-life depression and their treatment. J. Affect. Disord. 1985, (Suppl 1):S33-S40.
65. Srinivas S., Watanabe T., Lin C.S., William C.M., Tanabe Y., Jessell T.M., Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 2001, 1:4.
66. Tallquist M.D., Soriano P. Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 2000, 26:113-115.
67. Tan M., Walwyn W.M., Evans C.J., Xie C.W. p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons. J. Biol. Chem. 2009, 284:6270-6281.
68. Tao R., Auerbach S.B. Regulation of serotonin release by GABA and excitatory amino acids. J. Psychopharmacol. (Oxford) 2000, 14:100-113.
69. Thomas M.J., Kalivas P.W., Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br. J. Pharmacol. 2008, 154:327-342.
70. Wager-Smith K., Markou A. Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?. Neurosci. Biobehav. Rev. 2011, 35:742-764.
71. Wylie C.J., Hendricks T.J., Zhang B., Wang L., Lu P., Leahy P., Fox S., Maeno H., Deneris E.S. Distinct transcriptomes define rostral and caudal serotonin neurons. J. Neurosci. 2010, 30:670-684.
72. Xu M., Bruchas M.R., Ippolito D.L., Gendron L., Chavkin C. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase. J. Neurosci. 2007, 27:2570-2581.
73. Zarubin T., Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005, 15:11-18.
74. Zhang J., Shen B., Lin A. Novel strategies for inhibition of the p38 MAPK pathway. Trends Pharmacol. Sci. 2007, 28:286-295.
75. Zhao Z.Q., Gao Y.J., Sun Y.G., Zhao C.S., Gereau R.W., Chen Z.F. Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward. Proc. Natl. Acad. Sci. USA 2007, 104:14519-14524.
76. Zhen X., Du W., Romano A.G., Friedman E., Harvey J.A. The p38 mitogen-activated protein kinase is involved in associative learning in rabbits. J. Neurosci. 2001, 21:5513-5519.
77. Zhu C.B., Carneiro A.M., Dostmann W.R., Hewlett W.A., Blakely R.D. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J. Biol. Chem. 2005, 280:15649-15658.
78. Zhuang X., Masson J., Gingrich J.A., Rayport S., Hen R. Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J. Neurosci. Methods 2005, 143:27-32.
79. Zweifel L.S., Argilli E., Bonci A., Palmiter R.D. Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors. Neuron 2008, 59:486-496.